RNA interference using small interfering RNAs (siRNAs) has become a mainstay of functional gene characterization and has generated over a dozen FDA-approved therapeutics and drugs in late-stage ...
Figure 1: Design, preparation, and therapeutic mechanisms of PPCi NPs. (A) Self-assembly process of PPCi NPs. The opposite electrical properties of PEG- PEI (positively charged) and siRNA (negatively ...
MedPage Today on MSN
Cemdisiran siRNA therapy demonstrates efficacy in myasthenia gravis
Investigational treatment improves outcomes without complete complement blockade ...
Two start-ups have launched to develop next-generation drugs using small interfering RNA (siRNA) to silence genes. The first, Judo Bio, is a spin-off of the venture capital firm Atlas Venture. The ...
This is an introduction to the biological mechanism of RNA interference (RNAi) and experimental application of short, interfering RNA (siRNA). The key steps of the endogenous RNAi pathway will be ...
Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced the first patient has been dosed in multiple Phase II studies of ...
Spearheaded by patient-scientist Sonia Vallabh and Eric Minikel at the Broad Institute, a new drug candidate designed to slow the progression of prion disease is entering a phase 1 clinical trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results